US Patent 11857535 Methods of treating mutant lymphomas
Patent 11857535 was granted and assigned to Kymera Therapeutics on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+119 characters)
US Patent 11857535 Methods of treating mutant lymphomas
Article
Patent abstract
The present invention relates to methods of treating MYD88-mutant B-cell lymphomas using IRAK4 degrader.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Duncan Walker0
Date of Patent
January 2, 2024
0Patent Application Number
174440150
Date Filed
July 29, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11857535 Methods of treating mutant lymphomas
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
